Xenetic Biosciences, Inc. (XBIO)

NASDAQ: XBIO · Real-Time Price · USD

3.235

-0.240 (-6.91%)

At close: Sep 16, 2025, 4:00 PM EDT

3.240

+0.005 (0.15%)

After-hours: Sep 16, 2025, 7:35 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
Cell-based Therapeutics	2.54M	Log In	Log In	Log In	Log In	Upgrade
Cell-based Therapeutics Growth	48.80%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2016 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2016 - 2018
United States	2.54M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	48.80%	Log In	Log In	Log In	Log In	Upgrade